SDD can appear as several distinct patterns in the subretinal space, yet, to date, there is an incomplete understanding of why these morphological patterns emerge.
8,12 These patterns have previously been characterized as confluent, reticular (i.e. ribbon-like or a network-like structure), or multiple dots. In this paper, we demonstrate a mechanism by which the morphological features seen in the distribution of SDD could arise spontaneously, without reliance on an underlying pattern of cells in the retina, RPE, or choroid. Thus, SDD development could be spontaneous Turing patterns arising from the presence of a yet unknown activator and inhibitor agents. In our model, Turing patterns that resemble the full spectrum of SDD morphology were simulated using only two partial differential equations with simple assumptions; namely, that an activator is present and that there is an inhibitor that decreases the amount of the activator.
No organized pattern is seen when the strength of the activator is too high or too low. A low value of A (i.e. activator strength) when other parameters, including strength of the inhibitor, are held constant implies that the activator effect will be overwhelmed by the inhibitor, and no pattern will develop. Similarly, a high level of A indicates that there is overwhelming activation, which would be consistent with a confluent buildup of subretinal drusenoid deposit, as seen in the confluent pattern (see
Fig. 3). For intermediate values of reaction inhibition, our model generates the two other major morphological categories of SDD, dot and reticular.
Several additional pieces of evidence suggest that the spontaneous development of SDD morphology is an example of a Turing pattern. For example, SDDs tend to increase in anterior-posterior height over time, but not width.
3 This suggests an underlying 2D waveform driving SDD formation remains stable, even as more material accumulates in the subretinal space. This suggests that the pattern of SDD formation is an organized process over time, as opposed to a disorganized process, as may be the case in age-related accumulation of drusen in the sub-RPE space. Not all spots or deposits that arise in the subretinal or sub-RPE space would be expected to arise from Turing patterns, as not all “spots” that occur in the real world develop on this basis. Notably, other spots, such as drusen, do not show the high organization of reticular pseudodrusen or SDD, suggesting that drusen form by another, more random mechanism of spot formation. However, this analysis did not specifically analyze drusen.
It is important to note that different SDD patterns can be seen within the same retina. This implies that within the same patient, there can be significant regional topographic variation in inhibition of the formation of SDD. In one example from the literature, the full spectrum of the Turing pattern simulation can be seen in the same retina, with patterns arising in the same sequence predicted by the simulation (see
Fig. 4). In addition, the balance between the activator and inhibitor changes with age, because SDDs accumulate in patients as a function of age and are seldom seen in young adults. This implies that the reaction parameters change with patient age, or that the SDD accumulation is very slow and gradual.
Our model demonstrates that a reaction-diffusion system may exist to drive SDD formation, which can provide other investigators an understanding of SDD patterns as occurring along a spectrum and organizing future study of SDD characteristics in this order. However, this model does not allow us to identity the specific molecular activator or inhibitor of SDD formation. The biogenesis model for SDD formation expounded upon by Curcio et al., based on histologic analysis of SDD, also does not have immediate suggestions for activator-inhibitor candidates.
8,9 Additional studies are required to identify the molecular basis of SDD formation in the subretinal space.
SDDs have been demonstrated to independently increase the risk ratio of developing advanced AMD, including both neovascular AMD and geographic atrophy.
3,4,16–19 Some activation-inhibition systems have been implicated previously as risk factors for the development of advanced AMD, including the complement system, which has careful regulation through activator-inhibitor feedback systems. For example, complement factor H, whose gene may predispose some patients to developing AMD, is an important inhibitor of the alternate complement pathway.
20 In mouse models, an absence of
CFH leads to an organized accumulation of subretinal deposits in a dot-like conformation that appears to mimic some aspects of SDD in humans. Ultimately, this leads to significant downstream effects, including the upregulation of C3.
6 One study found variation in the distribution of CFH I62V polymorphisms between patients with dot-dominant and dot-reticular patterns (termed dot-ribbon, in this study).
7 However, there is conflict in the literature on whether this I62V polymorphism, and the Y402H variant, which is also associated with AMD, actually have higher prevalence in patients with subretinal drusenoid deposits.
21–24
Another possibility that may fit this activator-inhibitor system involves the vitamin A and retinoid cycles, which have previously been suggested to drive SDD formation based on OCT findings.
12 Specifically, vitamin A deficiency can cause subretinal, organized reticular patterns.
25,26 A defect of retinoid metabolism includes retinitis punctata albescens, which is caused by a mutation in retinaldehyde binding protein 1 (RLBP1), and fundus albipunctatus can be caused by mutations in the gene for retinol dehydrogenase 5 (RDH5), which participates in 11-cis-retinal synthesis. Both diseases have characteristic, highly organized dot-like subretinal lesions, and, in some cases, peripheral reticular patterns.
27 Here, disruption of the production and consumption in the retinoid cycle of 11-cis retinal may serve as the activator-inhibitor roles that would result in Turing pattern formation. It is important to note that other diseases can exhibit SDD, including Sorsby's macular dystrophy and pseudoxanthoma elasticum.
2,28 The fact that SDD may occur in a range of diseases suggests that the mechanism causing SDD are generalized, and possibly not disease specific.
There are intrinsic limitations to the current study. First, an incomplete understanding of the molecular basis of SDD formation makes it impossible to determine the exact reaction equations’ parameters at the current time.
3 Ideally, a more biologically specific formula would be specified, such as Michaelis-Menten equations. However, the substrates of the proposed reaction-diffusion system are unknown, and thus we have chosen to present the most general form of the equations driving Turing pattern formation. Second, a criticism of Turing pattern modeling in biological organisms is that they form over a narrow range of reaction parameters. In skin patterning, this criticism may be countered by allowing for evolutionary fine tuning of such parameters as there can be selection pressure associated with skin patterning. Here, however, no known evolutionary advantage is served by having SDD, but fine tuning may still be present as SDDs are only present in the small subset of the adult population (for example, one study found a prevalence of 5.06% in individuals 65 years or older).
29 Third, some studies have suggested that an alternate explanation may be that different patterns of SDD represent different disease processes.
12 However, this is unlikely because multiple patterns have been noted adjacent to each other in the same eye. Importantly, the clinical impact of this finding is still limited, but it may ultimately provide insight into the possible underlying mechanism for SDD formation. It is clinically interesting that the risk ratio of geographic atrophy for each pattern also follows the same order as the Turing pattern spectrum, with risk ratios for neovascular AMD following the opposite direction.
4 The significance of this finding is worthy of further investigation. Finally, whereas this model provides translational relevance by possibly explaining the variation in SDD patterns, in its present state, it does not explain all features of SDD, such as the tendency toward fovea sparing, or increased prevalence in women.
3